Publication | Open Access
Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2
186
Citations
56
References
2005
Year
These preclinical findings support the development of SAHA in combination with docetaxel and/or trastuzumab against Her-2-amplified breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1